187 related articles for article (PubMed ID: 34041675)
1. Hepatic sclerosed hemangioma and sclerosing cavernous hemangioma: a radiological study.
Jia C; Liu G; Wang X; Zhao D; Li R; Li H
Jpn J Radiol; 2021 Nov; 39(11):1059-1068. PubMed ID: 34041675
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of Hepatic Sclerosed Hemangiomas From Cavernous Hemangiomas Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Features.
Hwang JA; Kang TW; Cha DI; Kim SH; Ha SY; Kim SW
J Comput Assist Tomogr; 2019; 43(5):762-769. PubMed ID: 31356526
[TBL] [Abstract][Full Text] [Related]
3. Hepatic sclerosed hemangioma with special attention to diffusion-weighted magnetic resonance imaging.
Miyata T; Beppu T; Kuramoto K; Nakagawa S; Imai K; Hashimoto D; Namimoto T; Yamashita YI; Chikamoto A; Yamashita Y; Baba H
Surg Case Rep; 2018 Jan; 4(1):3. PubMed ID: 29299708
[TBL] [Abstract][Full Text] [Related]
4. Computed tomography and magnetic resonance imaging findings of nasal cavity hemangiomas according to histological type.
Kim JH; Park SW; Kim SC; Lim MK; Jang TY; Kim YJ; Kang YH; Lee HY
Korean J Radiol; 2015; 16(3):566-74. PubMed ID: 25995686
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of diffusion weighted MRI and ADC in differential diagnosis of cavernous hemangioma of the liver.
Tokgoz O; Unlu E; Unal I; Serifoglu I; Oz I; Aktas E; Caglar E
Afr Health Sci; 2016 Mar; 16(1):227-33. PubMed ID: 27358636
[TBL] [Abstract][Full Text] [Related]
6. Sclerosed hemangioma and sclerosing cavernous hemangioma of the liver: a comparative clinicopathologic and immunohistochemical study with emphasis on the role of mast cells in their histogenesis.
Makhlouf HR; Ishak KG
Liver; 2002 Feb; 22(1):70-8. PubMed ID: 11906621
[TBL] [Abstract][Full Text] [Related]
7. Hepatic cavernous hemangioma: appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression.
Soyer P; Dufresne AC; Somveille E; Scherrer A
AJR Am J Roentgenol; 1997 Feb; 168(2):461-5. PubMed ID: 9016227
[TBL] [Abstract][Full Text] [Related]
8. Atypically enhanced cavernous hemangiomas of the liver: centrifugal enhancement does not preclude the diagnosis of hepatic hemangioma.
Matsushita M; Takehara Y; Nasu H; Hirai Y; Yamashita S; Souda K; Kobayashi Y; Miura K
J Gastroenterol; 2006 Dec; 41(12):1227-30. PubMed ID: 17287903
[TBL] [Abstract][Full Text] [Related]
9. A hepatic sclerosed hemangioma with drastic changes in contrast-enhanced ultrasonography.
Akahoshi S; Yamamura K; Sato N; Oda E; Kinoshita K; Yuki H; Motohara T; Deguchi A; Komohara Y; Beppu T
Clin J Gastroenterol; 2020 Dec; 13(6):1252-1257. PubMed ID: 32705537
[TBL] [Abstract][Full Text] [Related]
10. Sclerosed hemangioma of the liver: concordance of MRI features with histologic characteristics.
Ridge CA; Shia J; Gerst SR; Do RK
J Magn Reson Imaging; 2014 Apr; 39(4):812-8. PubMed ID: 24783239
[TBL] [Abstract][Full Text] [Related]
11. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.
Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Kamimura K; Nakajo M
World J Gastroenterol; 2012 Nov; 18(43):6269-76. PubMed ID: 23180948
[TBL] [Abstract][Full Text] [Related]
12. [Orbital hemangiomas: capabilities of modern neuroradiological diagnostics].
Shchurova IN; Pronin IN; Mel'nikova-Pitskhelauri TV; Serova NK; Grigor'eva NN; Fadeeva LM; Shishkina LV
Zh Vopr Neirokhir Im N N Burdenko; 2018; 82(4):57-69. PubMed ID: 30137039
[TBL] [Abstract][Full Text] [Related]
13. Hepatic Sclerosed Hemangioma: a case report and review of the literature.
Miyamoto S; Oshita A; Daimaru Y; Sasaki M; Ohdan H; Nakamitsu A
BMC Surg; 2015 Apr; 15():45. PubMed ID: 25927893
[TBL] [Abstract][Full Text] [Related]
14. Preoperative diagnosis of the sclerosed hemangioma of the liver using multimodality imaging findings: A case report.
Ozaki K; Yoshikawa J; Yamamoto T; Maeda K; Kaizaki Y
Radiol Case Rep; 2018 Oct; 13(5):1025-1029. PubMed ID: 30228837
[TBL] [Abstract][Full Text] [Related]
15. Giant cavernous hemangioma of the liver: atypical CT and MR findings.
Valls C; Reñe M; Gil M; Sanchez A; Narvaez JA; Hidalgo F
Eur Radiol; 1996; 6(4):448-50. PubMed ID: 8798020
[TBL] [Abstract][Full Text] [Related]
16. Submillimeter-pixel MR images of hepatic cavernous hemangiomas.
Maeda H; Hayashi N; Toyooka N; Endoh S; Hayashi R
Radiat Med; 1997; 15(1):17-22. PubMed ID: 9134580
[TBL] [Abstract][Full Text] [Related]
17. Sclerotic changes of cavernous hemangioma in the cirrhotic liver: long-term follow-up using dynamic contrast-enhanced computed tomography.
Shin N; Choi JA; Choi JM; Cho ES; Kim JH; Chung JJ; Yu JS
Radiol Med; 2020 Dec; 125(12):1225-1232. PubMed ID: 32415477
[TBL] [Abstract][Full Text] [Related]
18. Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: value of contrast enhancement patterns.
Leslie DF; Johnson CD; Johnson CM; Ilstrup DM; Harmsen WS
AJR Am J Roentgenol; 1995 Mar; 164(3):625-9. PubMed ID: 7863883
[TBL] [Abstract][Full Text] [Related]
19. Is magnetic resonance imaging of hepatic hemangioma any different in liver fibrosis and cirrhosis compared to normal liver?
Duran R; Ronot M; Di Renzo S; Gregoli B; Van Beers BE; Vilgrain V
Eur J Radiol; 2015 May; 84(5):816-22. PubMed ID: 25703650
[TBL] [Abstract][Full Text] [Related]
20. Gadoxetic acid-enhanced MRI for differentiating hepatic sclerosing hemangioma from malignant tumor.
Kim YY; Kang TW; Cha DI; Min JH; Kim YK; Kim SH; Sinn DH; Won H; Kim S
Eur J Radiol; 2021 Feb; 135():109474. PubMed ID: 33352374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
